CRC. 7 Studies using cell lines and animal models suggest opposing roles of TH receptors α and β (TRα and TRβ, encoded by THRA and THRB, respectively) in CRC. Specifically, while TRα1 enhances intestinal carcinogenesis by positively regulating Wnt signaling, 2, 8, 9 TRβ1 expression is selectively lost upon malignant progression of CRC cells. 10, 11 The precise roles of TH signaling in CRC development thus remain elusive.
Thyroid hormone contains iodine atoms and its hormonal activity is tightly regulated by the 3 iodothyronine deiodinases in the body 12 ( Figure 1A ). In brief, DIO1 and DIO2 are TH-activating enzymes that convert the prohormone thyroxine (T4) in circulation to the active hormone triiodothyronine (T3) in peripheral tissues. T3 binds effectively to TH receptors and initiates TH signaling at target tissues.
Iodothyronine deiodinase 3 inactivates T3 and terminates its effects.
Iodothyronine deiodinase 2 is expressed in multiple tissues, whereas DIO1 expression is virtually restricted to the liver and kidney. 13 Iodothyronine deiodinase 2 has a ~500-fold higher affinity for T4 than DIO1. 14 Given the tissue distribution and enzymatic property, DIO2 is currently regarded as the central DIO that activates TH in the body. 12 A growing body of evidence indicates altered expression of DIOs in several types of cancers 13 and many cancer cell lines, including those from CRC highly express DIO3. [15] [16] [17] An in vitro study showed that inhibition of Wnt signaling, the key initial step for CRC development, 18 reduced DIO3 levels and induced DIO2 levels in Caco-2 cells. 15 Although these results suggest the involvement of DIOs in carcinogenesis, their roles in CRC development remain poorly understood.
Here we report elevated expression of DIO2 in the stroma of intestinal tumors in Apc Δ716 mice, a genetically engineered mouse model for familial adenomatous polyposis and the early stage of sporadic CRC. 19 Our study also shows that inhibition of DIOs suppresses the growth of intestinal tumors in Apc Δ716 mice and prolongs their survival, accompanied by reduced angiogenesis in the tumor microenvironment.
| MATERIAL S AND ME THODS

| Animals and drug treatments
The construction of Apc Δ716 mouse strain was described previously. 19 For inhibition of deiodinases, Apc Δ716 mice at 12 weeks of age were Cancer Center Research Institute (Nagoya, Japan).
| Histological analysis and IHC
For histological analysis and IHC, we used 5-μm sections of forma- 
| DNA microarray and real-time RT-PCR analysis
| Data and statistical analyses
Data and statistical analyses were undertaken using R (version 3.4.3; R Foundation for Statistical Computing). The single-channel Agilent DNA microarray raw data were preprocessed using the LIMMA package, 21 and differential expression analysis was carried out using the Rank products package. 22 The HTSeq-FKPM-UQ datasets of GDC TCGA Colon Cancer (COAD) and GDC TCGA Rectal Cancer (READ) were obtained from GDC Xena Hub run by the UC Santa Cruz Genomics Institute (https://xena.ucsc.edu). Recurrent and metastatic tumor datasets were excluded from these datasets. Enrichment analysis was undertaken using Metascape (http:// metascape.org). 23 Values of P < .05 were considered significant.
| RE SULTS
3.1 | Dio2 is highly expressed in stromal regions of intestinal polyps in Apc Δ716 mice
To identify molecules or signals involved in the tumor microenvironment of small intestinal polyps in Apc Δ716 mice, we first carried out differential gene expression analysis using DNA microarray. We found significant upregulation of Dio2 gene expression in the small intestinal polyps as compared with the normal small intestine tissue with the false discovery rate of 1.48 × 10 −2 (5.07-fold change; Figure 1B ).
Quantitative PCR analysis showed elevated expression level of Dio2 both in small intestinal and colonic polyps of Apc Δ716 mice ( Figure 1C ).
We next explored the site of expression of Dio2 in the Apc polyps, playing a key role in tumorigenesis of Apc Δ716 mice. 24 Immunohistochemistry analysis revealed that the Dio2-positive regions were mostly overlapped with the COX-2-positive areas in the tumor stroma ( Figure 2C ). Collectively, these results indicate that Dio2 mRNA is highly expressed in the stromal cells of Apc Δ716 polyps.
| Treatment with IOP suppresses polyp formation and prolongs survival in Apc Δ716 mice
Iopanoic acid, a classical oral cholecystography agent, contains 3 iodine atoms and potently inhibits DIO1 and DIO2 as shown in Figure 3A . 
| Chemically induced hypothyroidism suppresses polyp formation in Apc Δ716 mice
To confirm further the involvement of TH signaling in intestinal tumor formation in Apc Δ716 mice indicated by the IOP experiment, we carried out chemical thyroidectomy using MMI and PP. 26 The former disturbs the iodination of thyroglobulin in the thyroid gland, whereas PP acts as a competitive inhibitor of SLC5A5, a transporter responsible for the uptake of iodine into the thyroid gland. 27 Treatment with a cocktail of 0.02% (w/v) MMI and 1% (w/v) PP in drinking water reproducibly induces hypothyroidism in mice. 26 We confirmed the treatment regimen for 3 months ( Figure 4A ) completely depleted TH in the thyroid glands and disrupted the spherical follicles ( Figure 4B ), although we did not observe significant changes in general condition or body weight. The treatment with MMI + PP did not cause remarkable changes in tissue components of Apc Δ716 polyps ( Figure 4C ).
However, similar to IOP treatment, the chemical thyroidectomy significantly reduced the numbers of total polyps and those in the largesize class (≥1.5 mm) in Apc Δ716 mice ( Figures 4D and S1 ).
| Iodothyronine deiodinase 2 induces tumor cell proliferation and stimulates angiogenesis downstream of COX-2
To gain insights into the mechanism by which the inhibition of TH signaling or DIO2 suppresses the growth of Apc 
| DIO2 expression is increased in clinical samples of CRC
To address the expression profile of DIO2 in human CRC, we analyzed RNA sequencing datasets for colon and rectal cancer in TCGA database. 18 We found significant upregulation of DIO2 mRNA levels in primary tumor tissues of colon cancer as compared with the normal colon tissue ( Figure 6A ). The result is consistent with data provided in a recent review. 29 Rectal cancer gene expression data also showed upregulation of DIO2 mRNA in primary rectal tumor tissues ( Figure 6A) as compared with the normal rectal tissue. In situ hybridization for DIO2 using human colon cancer tissue samples indicated that DIO2 expression was restricted to the stromal region of colon cancer tissues ( Figure 6B ). Collectively, these results suggest the expression pattern of DIO2 in human CRC is highly similar to that of Dio2 in Apc Δ716 tumors ( Figure 2C ). Taken together, these data indicate that tumor stromal cells, rather than tumor epithelial cells, highly express DIO2 in CRC tissues.
We next explored genes that were highly coexpressed with DIO2 in CRC tissues. We first calculated Spearman's correlation coeffi- showed that COX-2 expression was not highly correlated with DIO2
( Figure 6E ). Immunohistochemistry analysis revealed that COX-2 was expressed both in the stromal and epithelial regions of human colon cancer samples ( Figure 6F ). The weaker correlation between COX-2 and DIO2 in human CRC could be explained by strong epithelial expression of COX-2 in advanced human CRC.
| D ISCUSS I ON
This study showed that DIO2 promotes intestinal tumor formation In the study, they showed that expression levels of DIO3, a TH inactivator, were elevated in clinical samples of colonic adenomas and CRC compared to normal colon tissues, and that DIO3 knockdown suppressed proliferation of CRC cells. 15 They also showed nearly restricted expression of DIO3 in the epithelial compartment of CRC, 
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F I G U R E 6 DIO2 expression is increased in the clinical samples of colorectal cancer. A, RNA sequencing analysis for DIO2 expression in colon and rectal cancer obtained from The Cancer Genome Atlas (TCGA) database (COAD and READ datasets 
